Yang, J.; Fang, M.; Hou, M.; Duan, Y.; Wang, J.; Hu, K.; Liu, S.; Liu, X.; Peng, X.; Ding, X.;
et al. VDR Decrease Enhances the Efficacy of 1,25-Dihydroxyvitamin D3 Inhibiting Gefitinib Resistance by Regulating EGFR/FASN Loop in NSCLC Cells. Pharmaceuticals 2025, 18, 1238.
https://doi.org/10.3390/ph18081238
AMA Style
Yang J, Fang M, Hou M, Duan Y, Wang J, Hu K, Liu S, Liu X, Peng X, Ding X,
et al. VDR Decrease Enhances the Efficacy of 1,25-Dihydroxyvitamin D3 Inhibiting Gefitinib Resistance by Regulating EGFR/FASN Loop in NSCLC Cells. Pharmaceuticals. 2025; 18(8):1238.
https://doi.org/10.3390/ph18081238
Chicago/Turabian Style
Yang, Junqing, Mingyu Fang, Mengjun Hou, Yalei Duan, Jiali Wang, Kaiyong Hu, Shuo Liu, Xiaoying Liu, Xiaohan Peng, Xuansheng Ding,
and et al. 2025. "VDR Decrease Enhances the Efficacy of 1,25-Dihydroxyvitamin D3 Inhibiting Gefitinib Resistance by Regulating EGFR/FASN Loop in NSCLC Cells" Pharmaceuticals 18, no. 8: 1238.
https://doi.org/10.3390/ph18081238
APA Style
Yang, J., Fang, M., Hou, M., Duan, Y., Wang, J., Hu, K., Liu, S., Liu, X., Peng, X., Ding, X., & Jia, Z.
(2025). VDR Decrease Enhances the Efficacy of 1,25-Dihydroxyvitamin D3 Inhibiting Gefitinib Resistance by Regulating EGFR/FASN Loop in NSCLC Cells. Pharmaceuticals, 18(8), 1238.
https://doi.org/10.3390/ph18081238